The blood is passed through a haemofiltration element (2) and a haemodialysis element (3) in cascade and the ultrafiltrate (7) output from the haemofiltration element (2) is passed through a filter (11) such as an activated carbon filter, preferably with uncoated activated carbon. The ultrafiltrate thus purified can then be used as a reinfusion solution (8) to be readministered to the patient. <IMAGE>
申请公布号
DE69025053(D1)
申请公布日期
1996.03.07
申请号
DE1990625053
申请日期
1990.12.18
申请人
BELLCO S.P.A., MIRANDOLA, MODENA, IT
发明人
GHEZZI, PAOLO, I-12016 PEVERAGNO (CUNEO), IT;GERVASIO, RENZO, I-10132 TORINO, IT